Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non–Small-Cell Lung Cancer

Title
Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
JAMA Oncology
Volume 1, Issue 2, Pages 196
Publisher
American Medical Association (AMA)
Online
2015-03-20
DOI
10.1001/jamaoncol.2015.0203

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation